Further, when clinical cholestasis markers were compared with the novel modalities for CFLD diagnosis assessed in this report, Bland-Altman Analyses revealed the presence of a proportional error in the agreement of γGT and the biomarkers TIMP-4 and Endoglin (Figure 9C) and in the agreement of ALP and TE (Figure 9D). This evidence concerns the gene ENG and cholestasis.